In Re: Xarelto (Rivaroxaban) Products Liability Litigation

  1. July 09, 2021

    Bayer, Janssen Duck Louisiana Blue Cross' Xarelto Claims

    A Louisiana federal judge has thrown out claims by the state's Blue Cross and Blue Shield alleging it was tricked into paying out for subscriptions to blood thinner Xarelto after Bayer Pharma AG and Janssen Pharmaceuticals Inc. misrepresented its safety, saying the health insurer can't draw a line between any wrongdoing by drugmakers and any harm it suffered.

  2. March 24, 2020

    Counsel To Get Up To $93M In Fees In Xarelto MDL

    A Louisiana federal judge has awarded counsel representing plaintiffs in multidistrict litigation alleging Bayer and Janssen Pharmaceuticals failed to warn about internal bleeding risks of the blood thinner Xarelto up to $93 million in fees and $23 million in costs for their work in securing a $775 million settlement.

  3. March 25, 2019

    Bayer, Janssen Pay $775M To End Xarelto Suits

    Bayer and Janssen Pharmaceuticals announced a $775 million deal Monday to settle about 25,000 lawsuits alleging that the companies failed to warn about internal bleeding risks caused by blood thinner Xarelto.

  4. July 17, 2018

    Product Liability Cases To Watch: Midyear Report

    The tsunami of litigation over the nation's deadly opioid crisis will continue to keep attorneys riveted as the parties work toward trial dates next year. And after a string of losses for patients who claim that Bayer failed to warn of its blood thinner Xarelto's bleeding risks, attorneys are looking to see if they can find a winning argument. Here are the product liability cases attorneys will be keeping an eye on for the rest of 2018.

  5. December 14, 2017

    Xarelto Bellwether Loser's New Trial Bid Rejected By Judge

    A Louisiana federal judge on Thursday refused to grant a new trial to a woman who lost a bellwether trial on claims that Janssen Pharmaceuticals' and Bayer's blood thinner Xarelto causes internal bleeding, rejecting her contention that a recent scientific study could have changed the jury's mind.

  6. October 20, 2017

    Xarelto Users Taking First Two Trial Losses To 5th Circ.

    Two consumers who lost bellwether trials claiming Bayer HealthCare Pharmaceuticals Inc. and Janssen Pharmaceuticals' bloodthinner Xarelto causes unstoppable bleeding have told a Louisiana federal court that they're going to appeal a handful of orders and the final judgments to the Fifth Circuit.

  7. October 11, 2017

    Xarelto Internal Bleeding Suit Nixed As Time-Barred

    A Louisiana federal judge on Tuesday axed a patient's suit in multidistrict litigation accusing Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. of not warning about the risks of blood thinner Xarelto, saying he filed his claims too late.

  8. September 20, 2017

    Xarelto Bellwether Loser Says New Study Merits Retrial

    A woman who lost a federal bellwether trial on claims that Janssen Pharmaceuticals' and Bayer's blood thinner Xarelto caused her hospitalization for internal bleeding has moved for a new trial, arguing jurors should see a recent study by Bayer scientists that contradicts the companies' trial testimony.

  9. September 19, 2017

    Bayer, Janssen Win Denial Of New Xarelto Trials

    A Louisiana federal judge on Tuesday declined to grant new trials to the plaintiffs in the first two bellwether trials in multidistrict litigation alleging Janssen and Bayer's blood thinner Xarelto caused unstoppable bleeding.

  10. August 18, 2017

    Jury Hands J&J, Bayer Win In 3rd Xarelto Bellwether

    A Mississippi federal jury on Friday sided with Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. in a bellwether case brought by a woman claiming the blood thinner Xarelto caused gastrointestinal bleeding that required her hospitalization, according to the plaintiff's and defendants' representatives.